Merck KGaA’s top-level changes continue with CEO transition; Incyte hires strategy execnews2025-09-26T11:00:12+00:00September 26th, 2025|Endpoints News|
Laura Shawver finds her next big bet; Sangamo CFO hands in resignationnews2025-09-19T11:00:34+00:00September 19th, 2025|Endpoints News|
Ousted FDA official joins Lilly; Novo names global research head as layoffs come into focusnews2025-09-12T11:00:45+00:00September 12th, 2025|Endpoints News|
Merck KGaA finds its next R&D leader; Exelixis retools management team as medical chief leavesnews2025-09-05T11:00:32+00:00September 5th, 2025|Endpoints News|
Longtime Novo Nordisk exec cites ‘recent shifts’ for his departure; Rocket Pharma CFO to resignnews2025-08-29T11:00:04+00:00August 29th, 2025|Endpoints News|
Lilly neuro exec Anne White to retire; Bristol Myers fills new medical affairs positionnews2025-08-22T11:00:32+00:00August 22nd, 2025|Endpoints News|
Stephen Hahn steps down as CEO of Flagship biotech; A new era at AbbVie partner Gubranews2025-08-15T11:00:03+00:00August 15th, 2025|Endpoints News|
Vor Bio hires former Sarepta exec to lead commercial strategy; Mallinckrodt poaches CFO from Incytenews2025-08-08T11:00:30+00:00August 8th, 2025|Endpoints News|
Novo Nordisk’s shakeup goes beyond a new CEO; Former FDAer snags regulatory role at GSKnews2025-08-01T11:00:23+00:00August 1st, 2025|Endpoints News|
Generate’s head of R&D returns to Merck; Galapagos shuffles leadership teamnews2025-07-25T11:00:19+00:00July 25th, 2025|Endpoints News|
